Growth Equity Fund Adjusts Addex Therapeutics Stake

TL;DR

Growth Equity Fund IV updated its Addex Therapeutics filing - watch for changes.

AI Summary

On August 14, 2024, Growth Equity Opportunities Fund IV, LLC filed an amendment to its Schedule 13D, reporting a change in beneficial ownership of Addex Therapeutics Ltd. The filing indicates a shift in holdings, though specific new percentages or dollar amounts are not detailed in this excerpt. The filing is an amendment, suggesting ongoing activity or adjustments by the fund regarding its investment in Addex Therapeutics.

Why It Matters

This filing signals a potential shift in major shareholder influence or strategy for Addex Therapeutics, which could impact its stock price and future corporate actions.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership by significant funds can indicate shifts in investment strategy or confidence, potentially affecting stock price.

Key Players & Entities

• Growth Equity Opportunities Fund IV, LLC (company) — Filing entity
• Addex Therapeutics Ltd. (company) — Subject company
• ANTHONY A. FLORENCE, JR. (person) — Group member
• FOREST BASKETT (person) — Group member
• MOHAMAD H. MAKHZOUMI (person) — Group member
• NEA 15 GP, LLC (company) — Group member
• NEA PARTNERS 15, L.P. (company) — Group member
• NEW ENTERPRISE ASSOCIATES 15, L.P. (company) — Group member
• SCOTT D. SANDELL (person) — Group member

FAQ

Key Financial Figures

• $7.90 — 3,560 Shares at prices that ranged from $7.90 to $8.05 per ADS. As of August 12, 2024
• $8.05 — res at prices that ranged from $7.90 to $8.05 per ADS. As of August 12, 2024, GEO hel

Filing Documents

• geoiv-addex_18864.htm (SC 13D/A) — 117KB
• 0001072613-24-000634.txt ( ) — 119KB

Security

Item 1. Security and Issuer . This Amendment No. 7 (“Amendment No. 7”) to Schedule 13D amends and supplements the statement on Schedule 13D originally filed on January 22, 2021, Amendment No. 1 filed on January 10, 2022, Amendment No. 2 filed on August 23, 2022, Amendment No. 3 filed on November 28, 2022, Amendment No. 4 filed on April 10, 2023, Amendment No. 5 filed on December 8, 2023, and Amendment No. 6 filed on August 5, 2024, relating to the shares, nominal value CHF 0.01 per share (the “Shares”), including Shares represented by American Depositary Shares (the “ADSs”), with each ADS representing one hundred and twenty Shares, of Addex Therapeutics Ltd. (the “Issuer”) having its principal executive office at Chemin des Mines 9, CH-1202 Geneva, Switzerland. Certain terms used but not defined in this Amendment No. 7 have the meanings assigned thereto in the Schedule 13D (and Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4 , Amendment No. 5 and Amendment No. 6 thereto). Except as specifically provided herein, this Amendment No. 7 does not modify any of the information previously reported on the Schedule 13D (and Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5 and Amendment No. 6 thereto).

Identity

Item 2. Identity and Background . This (a) Growth Equity Opportunities Fund IV, LLC (“GEO”); (b) New Enterprise Associates 15, L.P. (“NEA 15”), which is the sole member of GEO, NEA Partners 15, L.P. (“NEA Partners 15”), which is the sole general partner of NEA 15, and NEA 15 GP, LLC (“NEA 15 LLC” and, together with NEA Partners 15, the “Control Entities”), which is the sole general partner of NEA Partners 15; and (c) Forest Baskett (“Baskett”), Anthony A. Florence, Jr. (“Florence”), Mohamad H. Makhzoumi (“Makhzoumi”), Scott D. Sandell (“Sandell”) (together, the “Managers”). The Managers are the managers of NEA 15 LLC. The persons named in this Item 2 are referred to individually herein as a “Reporting Person” and collectively as the “Reporting Persons.” The address of the principal business office of each Control Entity and Sandell is New Enterprise Associates, 1954 Greenspring Drive, Suite 600, Timonium, MD 21093. The address of the principal business office of Baskett and Makhzoumi is New Enterprise Associates, 2855 Sand Hill Road, Menlo Park, CA 94025. The address of the principal business office of Florence is New Enterprise Associates, 104 Fifth Avenue, 19th Floor, New York, NY 10011. The principal business of GEO and NEA 15 is to invest in and assist growth-oriented businesses located principally in the United States. The principal business of NEA Partners 15 is to act as the sole general partner of NEA 15. The principal business of NEA 15 LLC is to act as the sole general partner of NEA Partners 15. The principal business of each of the Managers is to manage the Control Entities, GEO and a number of affiliated partnerships with similar businesses. During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding or has

Source

Item 3. Source and Amount of Funds or Other Consideration . Not applicable. CUSIP No.00654J206 13D Page 3 of 9 Pages

Purpose

Item 4. Purpose of Transaction . Not applicable.

Interest

Item 5. Interest in Securities of the Issuer . (c) From August 8, 2024 to August 12, 2024, GEO completed open market sales as part of a series of public sales whereby GEO sold in the aggregate 2,113 ADSs representing 253,560 Shares at prices that ranged from $7.90 to $8.05 per ADS. As of August 12, 2024, GEO held 4,315,130 Shares and a warrant to purchase 2,055,910 Shares. (e) Each of the Reporting Persons has ceased to beneficially own five percent (5%) or more of the Issuer’s Common Stock.

Contracts,

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer . Not applicable.

Material

Item 7. Material to be Filed as Exhibits . Exhibit 1 – Agreement regarding filing of joint Schedule 13D. Exhibit 2 – Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended. CUSIP No.00654J206 13D Page 4 of 9 Pages SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this EXECUTED this 14 th day of August, 2024 GROWTH EQUITY OPPORTUNITIES FUND IV, LLC By: NEW ENTERPRISE ASSOCIATES 15, L.P. Sole Member By: NEA PARTNERS 15, L.P. General Partner By: NEA 15 GP, LLC General Partner By: * Anthony A. Florence, Jr. Managing Partner and Co-Chief Executive Officer By: * Mohamad Makhzoumi Managing Partner and Co-Chief Executive Officer NEW ENTERPRISE ASSOCIATES 15, L.P. By: NEA PARTNERS 15, L.P. General Partner By: NEA 15 GP, LLC General Partner By: * Anthony A. Florence, Jr. Managing Partner and Co-Chief Executive Officer By: * Mohamad Makhzoumi Managing Partner and Co-Chief Executive Officer NEA PARTNERS 15, L.P. By: NEA 15 GP, LLC General Partner By: * Anthony A. Florence, Jr. Managing Partner and Co-Chief Executive Officer By: * M ohamad Makhzoumi Managing Partner and Co-Chief Executive Officer NEA 15 GP, LLC By: * Anthony A. Florence, Jr. Managing Partner and Co-Chief Executive Officer By: * Mohamad Makhzoumi Managing Partner and Co-Chief Executive Officer CUSIP No.00654J206 13D Page 5 of 9 Pages * Forest Baskett * Anthony A. Florence, Jr. * Mohamad H. Makhzoumi * Scott D. Sandell */s/ Zachary Bambach Zachary Bambach As attorney-in-fact This Amendment No. 7 to Schedule 13D was executed by Zachary Bambach on behalf of the individuals listed above pursuant to a Power of Attorney a copy of which is attached as Exhibit 2. CUSIP No.00654J206 13D Page 6 of 9 Pages EXHIBIT 1

View Full Filing

View this SC 13D/A filing on SEC EDGAR